Bank of America’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-192,300
Closed -$27.7M 7835
2025
Q3
$27.7M Buy
192,300
+180,000
+1,463% +$22.1M ﹤0.01% 2297
2025
Q2
$1.24M Sell
12,300
-14,700
-54% -$1.12M ﹤0.01% 5147
2025
Q1
$2.06M Buy
+27,000
New +$2.07M ﹤0.01% 4656
2017
Q4
Sell
-16,200
Closed -$506K 7126
2017
Q3
$506K Buy
+16,200
New +$309K ﹤0.01% 4945

Other funds holding INSM

Bank of America's INSM Position: Q1 2026 in Review

Bank of America reduced its Insmed (INSM) stake by 13% in Q1 2026, selling an estimated $34.3M and leaving 1,502,281 shares worth $246M. The position accounts for 0.02% of the portfolio, ranked #633.

Bank of America first reported a position in INSM in Q2 2013 and has held it in 52 quarters since. The position peaked at $300M in Q4 2025. 673 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

  • Bank of America held 1,502,281 shares of Insmed worth $246M as of Q1 2026.
  • Bank of America sold 223,400 Insmed shares in Q1 2026, an estimated $34.3M.
  • Insmed made up 0.02% of Bank of America's portfolio in Q1 2026, its #633 holding.
  • Bank of America first reported a position in Insmed in Q2 2013 and has held it in 52 quarters since.
  • Bank of America's Insmed position peaked at $300M in Q4 2025.
  • 673 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.